Overlap syndrome of asthma and COPD predicts low quality of life

Journal of Asthma

Volumn 48, Issue 3, 2011, Pages 279-285

  Kauppi, Paula ^a   Kupiainen, Henna ^b   Lindqvist, Ari ^b   Tammilehto, Lauri ^b   Kilpeläinen, Maritta ^c   Kinnula, Vuokko L ^b   Haahtela, Tari ^a   Laitinen, Tarja ^c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

asthma; COPD; quality of life

Indexed keywords

ADULT; ARTICLE; ASTHMA; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OBESITY; PENSION; QUALITY OF LIFE; RISK FACTOR; SELF REPORT;

ADULT; AGE FACTORS; AGED; ASTHMA; CARDIOVASCULAR DISEASES; COMORBIDITY; EMPLOYMENT; FEMALE; FINLAND; FORCED EXPIRATORY VOLUME; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PEAK EXPIRATORY FLOW RATE; PENSIONS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; RISK FACTORS; SEX FACTORS; SMOKING; SYNDROME; VITAL CAPACITY;

EID: 79952591815     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770903.2011.555576     Document Type: Article

References (33)

1. Gibson PG, Simson JL. The overlap syndrome of asthma and COPD: what areits features andhowimportant is it? Thorax 2009; 64:728-735.
2. von Hertzen LC, Mäkelä MJ, Petäys T, Jousilahti P, Kosunen TU, Laatikainen T, Vartiainen E, Haahtela T. Growing disparities in atopy between the Finns and the Russians\a comparison of two generations. J Allergy Clin Immunol 2008; 117:151-157. (Pubitemid 43017153)
3. Vartiainen E, Petäys T, Haahtela T, Jousilahti P, Pekkanen J. Allergic diseases, skin prick test responses, and IgE levels in North Karelia, Finland, and the Republic of Karelia, Russia. J Allergy Clin Immunol 2002; 109:643-648. (Pubitemid 34327191)
4. Pallasaho P, Lundbäck B, Läspä SL, Jönsson E, Kotaniemi J, Sovijärvi AR, Laitinen LA. Increasing prevalence of asthma but not of chronic bronchitis in Finland? Report from the FinEsS-Helsinki Study. Respir Med 1999; 93:798-809.
5. Kotaniemi JT, Lundbäck B, Nieminen MM, Sovijärvi ARA, Laitinen LA. Increase of asthma in adults in northern Finland? A report of FinEsS study. Allergy 2001; 56:169-174. (Pubitemid 32115769)
6. Kotaniemi J, Sovijärvi A, Lundbäck B. Chronic obstructive pul-monary disease in Finland: prevalence and risk factors. COPD 2005; 2: 331-339. (Pubitemid 43879449)
7. Soriano JB, Zielinski J, Price D. Screening for and early detec-tion of chronic obstructive pulmonary disease. Lancet 2009; 374: 721-732.
8. Marsh SE, Travers J, Weatherall M, Williams MV, Aldington S, Shirtcliffe PM, Hansell AL, Nowitz MR, Mcnaughton AA, Soriano JB, Beasley RW. Proportional classifications of COPD phenotypes. Thorax 2008; 63:761-767.
9. Mishima M. Physiological differences and similarities in asthma and COPD\based on respiratory function testing. Allergol Int 2009; 58:333-340.
10. Nakano Y, Van Tho N, Yamada H, Osawa M, Nagao T. Radiological approach to asthma and COPD\the role of computed tomography Allergol Int 2009; 58:323-331.
11. Beasley R, Weatherall M, Travers J, Shirtcliffe P. Time to define the disorders of the syndrome of COPD. Lancet 2009; 374: 667-668.
12. Viljanen AA, Halttunen PK, Kreus KE, Viljanen BC. Spirometric stud-ies in non-smoking, healthy adults. Scand J Clin Lab Invest 1982; 159:5-20. (Pubitemid 12127706)
13. British Thoracic Society Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Thorax 2008; 63:1-121.
14. Laitinen T, Hodgson U, Kupiainen H, Tammilehto L, Haahtela T, Kilpeläinen M, Lindqvist A, Kinnula VL. Real world clinical data iden-tifies gender related profiles in chronic obstructive pulmonary disease. COPD 2009; 6:256-262.
15. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF Pellegrino R, Viegi G, Wanger J; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J 2005; 26:319-338. (Pubitemid 41079078)
16. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-968. (Pubitemid 41632054)
17. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van WC, Zielinski J. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176:532-555. (Pubitemid 47403272)
18. Barley EA, Quirk FH, Jones PW. Asthma health status measurement in clinical practice: validity of a new short and simple instrument. Respir Med 1998; 92:1207-1214. (Pubitemid 28502363)
19. Hajiro T, Nishimura K, Jones PW, Tsukino M, Ikeda A, Koyama H, Izumi T. A novel, short, and simple questionnaire to mea-sure health-related quality of life in patients with chronic obstruc-tive pulmonary disease. Am J Respir Crit Care Med 1999; 159: 1874-1878. (Pubitemid 29275057)
20. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M. Comparison of the responsiveness of different disease-specific health status measures in patients with asthma. Chest 2002; 122: 1228-1233. (Pubitemid 35339534)
21. Kauppinen R, Rissanen P, Sintonen H. Agreement between a generic and disease-specific quality-of-life instrument: the 15D and the SGRQ in asthmatic patients. Qual Life Res 2000; 9:997-1003.
22. Celli BR, Halbert RJ, Isonaka S, Schau B. Population impact of different definitions of airway obstruction. Eur Respir J 2003; 22: 268-273. (Pubitemid 36986996)
23. Browatzki A, Ulrik CS, Lange P. Prevalence and severity of self-reported asthma in young adults. Eur Respir J 2009; 34: 1046-1051.
24. Lavoie KL, Bacon SL, Labrecque M, Cartier A, Ditto B. Higher BMI is associated with worse asthma control and quality of life but not asthma severity. Respir Med 2006; 100:648-657. (Pubitemid 43285752)
25. Mosen DM, Schatz M, Magid DJ, Camargo CA. The relationship between obesity and asthma severity and control in adults. J Allergy Clin Immunol 2008; 122:507-511.
26. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet 2009; 374:733-743.
27. Weatherall M, Travers J, Shirtcliffe PM, Marsh SE, Williams MV, Nowitz MR, Aldington S, Beasley R. Distinct clinical phenotypes of airways disease defined by cluster analysis. Eur Respir J 2009; 34:812-818.
28. Orie NGM, Sluiter HJ, eds. Bronchitis II: Second International Symposium. Assen, The Netherlands: Royal Van Gorcum 1964, 398-399.
29. Postma DS, Boetzen M. Rationalefor the Dutch hypothesis, allergy and airway hyperresponsiveness as genetic factors and their interaction with environment in the development of asthma and COPD. Chest 2004; 126:96S-104S. (Pubitemid 39093398)
30. Barnes PJ. Against the Dutch hypothesis: asthma and chronic obstruc-tive pulmonary disease are distinct diseases. Am J Respir Crit Care Med 2006; 174:240-243.
31. Hahn DL. Beyond the Dutch hypothesis. Am J Respir Crit Care Med 2006; 174:1056-1057.
32. Reddel HK, Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB, Chanez P, Enright PL, Gibson PG, de Jongste JC, Kerstjens HA, Lazarus SC, Levy ML, O'Byrne PM, Partridge MR, Pavord ID, Sears MR, Sterk PJ, Stoloff SW, Sullivan SD, Szefler SJ, Thomas MD, Wenzel SE; American Thoracic Society/European Respiratory Society Task Force on Asthma Control and Exacerbations. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med2009; 180:59-99.
33. Sinn DD, Tashkin D, Zhang X, Radner F, Sjöbring U, Thorén A, Calverley PMA, Rennard SI. Budesonide and the risk of pneumonia: a meta-analysis ofindividual patient. Lancet 2009; 374:712-719.